DME Capital Management’s Henry Schein HSIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60M Buy
718,550
+119,250
+20% +$9.12M 1.54% 24
2026
Q1
$44.2M Buy
599,300
+130,050
+28% +$10M 1.38% 25
2025
Q4
$35.5M Buy
+469,250
New +$33M 1.24% 22

Other funds holding HSIC

DME Capital Management's HSIC Position: Q2 2026 in Review

DME Capital Management increased its Henry Schein (HSIC) stake by 20% in Q2 2026, buying an estimated $9.12M and bringing the position to 718,550 shares worth $60M. The position accounts for 1.54% of the portfolio, ranked #24.

DME Capital Management first reported a position in HSIC in Q4 2025 and has held it in 3 quarters since. 562 funds tracked by Wall St. Rank hold HSIC as of Q2 2026.

  • DME Capital Management held 718,550 shares of Henry Schein worth $60M as of Q2 2026.
  • DME Capital Management bought 119,250 Henry Schein shares in Q2 2026, an estimated $9.12M.
  • Henry Schein made up 1.54% of DME Capital Management's portfolio in Q2 2026, its #24 holding.
  • DME Capital Management first reported a position in Henry Schein in Q4 2025 and has held it in 3 quarters since.
  • 562 funds tracked by Wall St. Rank held Henry Schein as of Q2 2026.

Based on DME Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.